HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thromboxane A2 antagonistic action of a new anti-ulcer agent, azuletil sodium (KT1-32).

Abstract
The TXA2/PGH2 receptor antagonistic activity of azuletil sodium (KT1-32), a new anti-ulcer agent, was examined. KT1-32 competitively antagonized the contraction of canine gastric arteries induced by U-46619, PGF2 alpha, and PGE2, whereas it had no effect on the PGF2 alpha-, PGE2- and LTD4-induced contraction of guinea-pig ileum, which was not affected by U-46619. In anesthetized dogs, KT1-32 significantly reduced the U-46619-induced decrease in gastric arterial blood flow. Gastric contraction induced by U-46619 in anesthetized rats was markedly inhibited by KT1-32. KT1-32 showed no influence on TXA2 synthetase and cyclooxygenase activities. These results indicate that KT1-32 is a competitive TXA2/PGH2 receptor antagonist, which may be important as to the effectiveness of KT1-32 against gastric ulcer.
AuthorsS Mochizuki, S Wakabayashi, A Tomiyama, N Satake, S Shibata
JournalScandinavian journal of gastroenterology. Supplement (Scand J Gastroenterol Suppl) Vol. 162 Pg. 194-7 ( 1989) ISSN: 0085-5928 [Print] England
PMID2595296 (Publication Type: Journal Article)
Chemical References
  • Anti-Ulcer Agents
  • Azulenes
  • Prostaglandin Endoperoxides, Synthetic
  • Sesquiterpenes
  • azulene SN
  • Thromboxane A2
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • azuletil
Topics
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Animals
  • Anti-Ulcer Agents (pharmacology)
  • Arteries
  • Azulenes
  • Dogs
  • Guinea Pigs
  • Male
  • Muscle Contraction (drug effects)
  • Prostaglandin Endoperoxides, Synthetic (antagonists & inhibitors, pharmacology)
  • Pylorus (blood supply)
  • Rats
  • Rats, Inbred Strains
  • Regional Blood Flow (drug effects)
  • Sesquiterpenes (pharmacology)
  • Stomach (blood supply, drug effects)
  • Thromboxane A2 (antagonists & inhibitors)
  • Vasoconstriction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: